These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34432954)

  • 1. EGFR analysis on scrapings from cytology smears in lung carcinoma, an effective alternative to testing on trucut biopsies.
    Mohan AA; Vallonthaiel AG; Nambiar A; Ariyannur P; Joy RA; Thelakkattusserry SK; Vikkath N; Joseph T; Mehta A; Perathur A
    Diagn Cytopathol; 2021 Oct; 49(10):1155-1163. PubMed ID: 34432954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer.
    Lozano MD; Labiano T; Echeveste J; Gurpide A; Martín-Algarra S; Zhang G; Sharma A; Palma JF
    Cancer Cytopathol; 2015 Apr; 123(4):230-6. PubMed ID: 25529460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell HE staining smears and paired cell paraffin sections in detection of epithelial growth factor receptor gene of pleural fluid specimens.
    Hou F; Qi C; Lu Y; Li F; Hao Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):35-44. PubMed ID: 35545361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Confirmed Cytology Smears and Cell Blocks for Epidermal Growth Factor Receptor Mutation Testing in Non-Small Cell Lung Cancer.
    Liu CH; Chang SJ; Tsai MJ; Yang SF
    Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):701-706. PubMed ID: 37807651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.
    Lozano MD; Zulueta JJ; Echeveste JI; Gúrpide A; Seijo LM; Martín-Algarra S; Del Barrio A; Pio R; Idoate MA; Labiano T; Perez-Gracia JL
    Oncologist; 2011; 16(6):877-85. PubMed ID: 21572125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas.
    Khode R; Larsen DA; Culbreath BC; Parrish S; Walker KL; Sayage-Rabie L; Beissner RS; Rao A
    Cancer Cytopathol; 2013 Jul; 121(7):361-9. PubMed ID: 23364874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
    Treece AL; Montgomery ND; Patel NM; Civalier CJ; Dodd LG; Gulley ML; Booker JK; Weck KE
    Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.
    Ellison G; Zhu G; Moulis A; Dearden S; Speake G; McCormack R
    J Clin Pathol; 2013 Feb; 66(2):79-89. PubMed ID: 23172555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the SuperARMS and ARMS for detecting EGFR mutations in liquid-based cytology specimens from NSCLC patients.
    Wu W; Cao Z; Zhang W; Zhang L; Hou L; Wu C
    Diagn Pathol; 2020 Jan; 15(1):9. PubMed ID: 32005253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR mutation testing using archival-stained smears in non-small cell lung carcinoma.
    Ozluk Y; Firat P; Yegen G; Hocaoglu J; Tas S; Yilmazbayhan D
    Cytopathology; 2017 Feb; 28(1):35-45. PubMed ID: 27389045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy).
    de Biase D; Visani M; Malapelle U; Simonato F; Cesari V; Bellevicine C; Pession A; Troncone G; Fassina A; Tallini G
    PLoS One; 2013; 8(12):e83607. PubMed ID: 24376723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancer.
    Powrózek T; Krawczyk P; Pankowski J; Reszka K; Jakubiak M; Obrochta A; Wojas-Krawczyk K; Buczkowski J; Milanowski J
    Tumori; 2015 Nov; 101(6):e151-3. PubMed ID: 26108238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR testing in paraffin-embedded cell block cytology material is reliable with increased detection for effusion fluid.
    Man Ng JK; Chow C; Kin Chan RC; Pang Chan K; Xi Li JJ; Ching Li MS; To KF
    Lung Cancer; 2022 Dec; 174():97-103. PubMed ID: 36356494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced non-small cell lung cancer: Rapid evaluation of EGFR status on fine-needle cytology samples using Idylla.
    D'Ardia A; Caputo A; Fumo R; Ciaparrone C; Gaeta S; Picariello C; Zeppa P; D'Antonio A
    Pathol Res Pract; 2021 Aug; 224():153547. PubMed ID: 34280752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.
    Li W; Zhang Z; Guo L; Qiu T; Ling Y; Cao J; Guo H; Zhao H; Li L; Ying J
    Oncotarget; 2016 Feb; 7(7):8332-40. PubMed ID: 26789109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing.
    Rekhtman N; Brandt SM; Sigel CS; Friedlander MA; Riely GJ; Travis WD; Zakowski MF; Moreira AL
    J Thorac Oncol; 2011 Mar; 6(3):451-8. PubMed ID: 21266922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer.
    Lee SE; Lee SY; Park HK; Oh SY; Kim HJ; Lee KY; Kim WS
    J Korean Med Sci; 2016 Aug; 31(8):1224-30. PubMed ID: 27478332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
    Liu Y; Wu BQ; Zhong HH; Hui P; Fang WG
    Int J Clin Exp Pathol; 2013; 6(9):1880-9. PubMed ID: 24040454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens.
    Xu H; Sun W; Zhang G; Cheng Y
    J BUON; 2015; 20(1):142-5. PubMed ID: 25778309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of an EGFR mutation in cytological specimens of lung adenocarcinoma.
    Mohar B; Smojver Ježek S; Rajković Molek K; Štemberger C; Kurpis M; Kupanovac Ž; Samaržija M; Jonjić N; Grahovac B
    Cytopathology; 2016 Dec; 27(6):444-451. PubMed ID: 26990359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.